Asset Allocation

As of September 30, 2026.
Type % Net
Cash 24.89%
Stock 29.75%
Bond 52.15%
Convertible 0.00%
Preferred 0.00%
Other -6.79%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 84.05%    % Emerging Markets: 0.11%    % Unidentified Markets: 15.84%

Americas 83.49%
82.73%
Canada 0.13%
United States 82.60%
0.75%
Colombia 0.01%
As of September 30, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.61%
United Kingdom 0.19%
0.39%
Belgium 0.00%
France 0.03%
Ireland 0.13%
Italy 0.01%
Switzerland 0.14%
0.00%
0.03%
Israel 0.03%
Saudi Arabia 0.00%
United Arab Emirates 0.00%
Greater Asia 0.07%
Japan 0.00%
0.00%
Australia 0.00%
0.06%
Singapore 0.06%
0.00%
Unidentified Region 15.84%

Bond Credit Quality Exposure

AAA 0.00%
AA 16.93%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 83.07%
Short Term 0.00%
As of September 30, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
37.49%
Materials
4.16%
Consumer Discretionary
8.95%
Financials
18.84%
Real Estate
5.54%
Sensitive
36.70%
Communication Services
2.48%
Energy
6.68%
Industrials
13.79%
Information Technology
13.75%
Defensive
25.39%
Consumer Staples
1.96%
Health Care
20.70%
Utilities
2.72%
Not Classified
0.42%
Non Classified Equity
0.42%
As of September 30, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of September 30, 2026
Type % Net
Government 100.00%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
96.68%
Less than 1 Year
96.68%
Intermediate
3.32%
1 to 3 Years
3.32%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of September 30, 2026
View Bond Maturity Exposure
Start Trial